Biocept (BIOC) Misses Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Biocept Reports Second Quarter 2021 Financial Results
August 16, 2021 4:05 PM EDTSecond quarter revenues of $12.0 million driven by RT-PCR COVID-19 testing Continued sequential-quarter CNSide volume growth with customer base expanding to more than 30 leading U.S. academic institutions, including multiple repeat users Issued coverage with high-value payment by Medicare for the Target Selector breast cancer assay to detect the HER2 biomarker Received nearly 500,000 samples for COVID-19 RT-PCR testing since June 2020
Conference call begins at 4:30 p.m. Eastern time today
SAN DIEGO--(BUSINESS... More
